Payors, Health Systems & Healthcare Providers

Reduce costs and improve outcomes associated with Asthma and COPD

Increase inhaler adherence and improve technique.
90% Of patients with Asthma & COPD take their inhaler incorrectly resulting in <20% of medication reaching a user’s lungs. This has a negative impact on patient outcomes and increases the costs associated with managing these conditions.
Supplying the BreatheSuite MDI Device to patients is an effective and efficient way to remotely provide individualized care that will increase inhaler adherence and technique, while decreasing  the overall economic burden associated with these conditions.

North American Yearly Expenditures (Asthma + COPD)*

Your Organization


Request a Demo
Learn how your organization and clients can benefit from incorporating BreatheSuite into your practice
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

*AL-Jahdali et al. (2013). Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Retrieved from
Lewis, A. (2016). The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique..”. Retrieved from

Cookie Notice
Please know that cookies are required to operate and enhance our products and services, as well as for advertising and analytical purposes. We value your privacy. If you are not comfortable with us collecting and using cookies, please review your settings before continuing.
Our Privacy Policy